AU Patent

AU2016340167A8 — Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Assigned to AbbVie Inc · Expires 2018-05-10 · 8y expired

What this patent protects

The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3

USPTO Abstract

The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3

Drugs covered by this patent

Patent Metadata

Patent number
AU2016340167A8
Jurisdiction
AU
Classification
—
Expires
2018-05-10
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.